Hybrid Nanostructures for Cancer Theranostics

Hybrid nanostructures are nanoparticles which incorporate two or more structures. These structures may represent organic or inorganic material, but they synergistically improve the application of the material for end users. Hybrid Nanostructures for Cancer Theranostics explores how hybrid nanostructures are used in cancer treatment.

Focusing on the properties of hybrid nanostructures, the book demonstrates how their unique characteristics can be used to create more effective treatment techniques. In the second half of the book, the chapters examine how hybrid nanostructures are currently being used in practice, assessing the pros and cons of using different types of nanostructures for different treatments.

This valuable resource will allow readers to understand the core and emerging concept of functionalization, bioconjugation, hyperthermia and phototherapy of nanoparticles which allows for the greater use of hybrid nanomaterials in cancer theranostics.

• Shows how the use of novel hybrid nanostructures can lead to more effective cancer treatments.
• Explores how hybrid nanostructures are used for different treatment types, including photo thermal therapy and drug delivery.
• Explains how the use of hybrid nanostructures can lead to more rapid cancer diagnosis.

Dr. Raghvendra A. Bohara, MSc, PhD, is an Assistant Professor at the Centre for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be University), Kolhapur, India, and a Government of Ireland IRC Postdoctoral Fellow at CÚRAM, National University of Ireland Galway. He collaborates closely with Prof. Abhay Pandit and has established research partnerships with colleagues across India, South Korea, Japan, Taiwan, Ireland, the USA, Germany, Poland, Saudi Arabia, and Australia. Dr. Bohara has received several prestigious fellowships and awards for his research contributions. He is actively involved in teaching, supervising doctoral students, and participating in outreach and scientific dissemination. He serves as Associate Editor for Biochemistry and Biophysics Reports (Elsevier), has experience as a guest editor and reviewer, and holds key roles in research ethics and innovation at his institution. His main research interests are magnetic-triggered drug delivery and cancer nanomedicine

Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK.

He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commission’s innovation Radar “Grand Prix of the Innovation Radar Prize 2020” for developing ground-breaking technology for breast cancer theranostics.